| CXSB2200096 | 人源化抗人TNFα单克隆抗体注射液（CHO细胞） | adalimumab | Injection | Biological Products(1) | Supplementary Application | 2022-11-08 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSB2101002 | 人源化抗人TNFα单克隆抗体注射液（CHO细胞） | adalimumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-18 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| J0300782 | 肿瘤坏死因子α单克隆抗体注射剂 | adalimumab | Injection | Biological Products(7) | Import Drug Application | 2004-06-09 | Abbott Laboratories Ltd | Abbott Laboratories Ltd | Certificate Issued | 2004-12-27 | view |
| CXSL1500080 | 重组全人源抗肿瘤坏死因子-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2015-10-19 | 上海华奥泰生物药业有限公司 | Shanghai Huaota Biopharmaceutical Co Ltd | Certificate Issued | 2016-12-30 | view |
| CXSL1700057 | 重组全人源抗肿瘤坏死因子-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2017-07-20 | 上海华奥泰生物药业有限公司 | Shanghai Huaota Biopharmaceutical Co Ltd | Certificate Issued | 2018-06-28 | view |
| CXSL1600095 | 重组抗TNFα全人单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2016-12-12 | 上海复宏汉霖生物技术有限公司 | Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2017-04-20 | view |
| CXSL1300056 | 重组抗TNFα全人单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2013-12-23 | 上海复宏汉霖生物技术有限公司 | Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2016-01-14 | view |
| CXSL1700013 | 重组抗肿瘤坏死因子α全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2017-04-24 | 上海谐生医药科技有限公司 | Shanghai Xiesheng Medical Technology Co Ltd | Certificate Issued | 2018-03-20 | view |
| CXSL1400118 | 重组抗TNFα全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2015-03-24 | 上海迈泰亚博生物技术有限公司 | Shanghai MabLab Biotechnology Co Ltd | Certificate Issued | 2016-09-03 | view |
| CXSL1400002 | 重组人抗肿瘤坏死因子-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2014-02-17 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2016-01-13 | view |
| CXSB1700005 | 重组人抗肿瘤坏死因子-α单克隆抗体注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2017-08-18 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2018-01-17 | view |
| CXSL1400005 | 重组人抗肿瘤坏死因子-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2014-02-19 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2016-01-13 | view |
| CXSL1500023 | 重组抗肿瘤坏死因子-α全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2015-05-08 | 北京东方百泰生物科技有限公司 | Beijing Dongfang Biotech Co Ltd | Certificate Issued | 2017-02-13 | view |
| CXSL1700017 | 重组全人源抗TNF-α单抗注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2017-09-14 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | Certificate Issued | 2018-09-03 | view |
| CXSL1600064 | 抗人肿瘤坏死因子-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2016-11-10 | 北京绿竹生物技术股份有限公司 | Beijing Lvzhu Biological Technology Co Ltd | Certificate Issued | 2017-11-21 | view |
| CXSL1400098 | 抗人肿瘤坏死因子-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2015-01-19 | 北京绿竹生物技术股份有限公司 | Beijing Lvzhu Biological Technology Co Ltd | Certificate Issued | 2016-05-12 | view |
| CXSL1500032 | 重组人源抗人肿瘤坏死因子(TNF-α)单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2015-05-13 | 华北制药集团新药研究开发有限责任公司 | North China Pharmaceutical Group New Drug R&D Co Ltd | Certificate Issued | 2017-02-13 | view |
| CXSL1300050 | 肿瘤坏死因子α重组全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2013-08-16 | 吉林康慧生物科技有限公司 | Alphamab Jilin Co Ltd | Certificate Issued | 2016-01-14 | view |
| CXSL1300035 | 重组抗肿瘤坏死因子-α全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2013-07-22 | 嘉和生物药业有限公司 | Genor Biopharma Co Ltd | Certificate Issued | 2016-03-28 | view |
| CXSL1600065 | 抗TNFα全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2016-09-02 | 大庆东竺明生物技术有限公司 | DZM Biotech Ltd | Certificate Issued | 2017-05-22 | view |
